Posted inNews and Updates
FDA Expands Finerenone Approval for CKD in Type 1 Diabetes
The FDA has approved finerenone for patients with CKD and type 1 diabetes. Learn about this breakthrough treatment's impact on cardiorenal health.
Posted inNews and Updates
China Biotech Deals: Regulatory Risks and Market Outlook
Explore how the COINS Act, major WCLC clinical data, and new biotech leadership are shaping the future of global pharmaceutical deals and market stability.
Posted inNews and Updates
The Rise of Biopharma Prediction Markets Explained
Explore how biopharma prediction markets are reshaping clinical trial forecasting and drug development insights through collective intelligence.
Posted inNews and Updates
Can Maternal Diet Prevent Infant Allergies? New Study Results
New research shows that high intake of eggs and peanuts during pregnancy fails to prevent infant allergies. Discover what this means for maternal diet.
Posted inNews and Updates
Nu-3 Phase 2a Trial Launched for Diabetic Foot Ulcers
Lakewood-Amedex has received IRB approval for a Phase 2a trial of Nu-3, a novel treatment targeting infected diabetic foot ulcers. Learn more about the study.
Posted inNews and Updates
FDA Regulatory Delays: The Risks of Unfinished Drug Studies
FDA-mandated drug and device studies are years behind schedule. Discover the safety implications of these unfinished clinical trials on public health.
Posted inNews and Updates
FDA Grants Priority Review to Leo Pharma’s New Therapy
The FDA has granted Priority Review to a new drug acquired by LEO Pharma. Learn what this expedited regulatory path means for patients and the industry.
Posted inNews and Updates
Nonmelanoma Skin Cancer Rates Underreported by 42%
New data reveals nonmelanoma skin cancer rates are 42% higher than officially reported. Learn how this undercounting impacts healthcare and diagnostics.
Posted inNews and Updates
Rabies Exposure Inquiries Rise: KedRAB Supply Update
A 17% rise in rabies inquiries has sparked concern. Learn about the current availability of KedRAB and essential post-exposure protocols for patients.
Posted inNews and Updates
New CCTV Mandate Proposed for Pharmacies to Curb Drug Abuse
India proposes mandatory CCTV for pharmacies to monitor Schedule H, H1, and X drug sales, aiming to curb substance abuse and ensure strict compliance.